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SUMMARY 62 
Methanobactins (mbs) are low molecular mass (< 1,200 Da) copper-binding peptides, or 63 
chalkophores, produced by many methane-oxidizing bacteria (methanotrophs).  These molecules 64 
exhibit similarities to certain iron-binding siderophores, but are expressed and secreted in 65 
response to copper limitation. Structurally, mbs are characterized by a pair of heterocyclic rings 66 
with associated thioamide groups that form the copper coordination site.  One of the rings is 67 
always an oxazolone and the second ring an oxazolone, imidazolone, or a pyrazinedione moiety.  68 
The mb molecule originates from a peptide precursor that undergoes a series of post-translational 69 
modifications including: (1) ring formation; (2) cleavage of a leader peptide sequence, and, in 70 
some cases, (3) addition of a sulfate group.   71 
 Functionally, mbs represent the extracellular component of a copper acquisition system.  72 
Consistent with this role in copper acquisition, mbs have a high affinity for copper ions.  73 
Following binding, mbs rapidly reduce Cu2+ to Cu1+.  In addition to copper, mbs will bind most 74 
transition metals and near transition metals and protect the host methanotroph as well as other 75 
bacteria from toxic metals. Several other physiological functions have been assigned to mbs, 76 
based primarily on their redox and metal binding properties. In this review, we examine the 77 
current state of knowledge of this novel type of metal-binding peptide.  We also explore its 78 
potential applications, how mbs may alter the bioavailability of multiple metals, as well as the 79 
many roles mbs may play in the physiology of methanotrophs. 80 
 81 
INTRODUCTION 82 
Mbs were first identified in aerobic methane oxidizing bacteria (methanotrophs).  This 83 
remarkable group of bacteria can grow using methane as their sole source of carbon and energy. 84 
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They are ubiquitous in environments where oxygen and methane are available, and play a major 85 
role in consuming much of the methane produced in the biosphere, thus mitigating its effects in 86 
global warming (1-4). Due to their growth on an inexpensive, readily available and, if generated 87 
via methanogenesis (5), a renewable carbon source, methanotrophs also have considerable 88 
potential for the production of bulk and fine chemicals and for bioremediation of pollutants in 89 
the environment (2, 6-8). 90 
 The first report of a bacterium growing on methane was by Söhngen, working in 91 
Beijerinck’s laboratory in Delft in The Netherlands, who in 1906 reported the isolation of 92 
Bacillus methanicus from aquatic plants and pond water (9).  It was not until 50 years later that 93 
this microbe was re-isolated and renamed Pseudomonas methanica (10, 11). A second 94 
methanotroph, Methylococcus capsulatus (Texas strain) was also isolated in 1966 (12). A 95 
landmark in methanotroph biology came in 1970 when Whittenbury and colleagues isolated and 96 
described, from a variety of terrestrial and freshwater environments, over 100 new aerobic 97 
methanotrophs growing on methane (13). They then devised a classification scheme, i.e. Type I 98 
vs. Type II, based on the ability of these methanotrophs to grow on methane, pathways of carbon 99 
assimilation, formation of resting stages (cysts and spores), morphology, the possession of 100 
complex intracytoplasmic membrane arrangements, and the mol% G + C content of their DNA.  101 
Subsequently, Bowman and colleagues isolated a similar number of methanotrophs from various 102 
environments, and classified them according to the scheme of Whittenbury and colleagues and to 103 
their 16S rRNA phylogeny (14, 15). It is remarkable that without any DNA sequencing at the 104 
time, the overall classification scheme of Whittenbury and colleagues still remains a robust and 105 
convenient way of grouping methanotrophs today.  106 
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 Accordingly, there are currently 17 genera of methanotrophs within the family 107 
Methylococcaceae. In the class Gammaproteobacteria, known genera are Methylobacter, 108 
Methylocaldum, Methylococcus, Methylogaea, Methyloglobulus, Methylohalobius, 109 
Methylomarinum, Methylomarinovum, Methylomicrobium, Methylomonas, Methyloparacoccus, 110 
Methyloprofundus, Methylosoma, Methylothermus, Methylosphaera, Methylosarcina and 111 
Methylovulum (16-21).  Within the class Alphaproteobacteria, the genera Methylosinus and 112 
Methylocystis are found in the family Methylocystaceae, and genera Methylocella, Methyloferula 113 
and Methylocapsa in the family Beijerinkiaceae. In the last 15 years, there have been increasing 114 
reports of facultative methanotrophs within the Methylocella, Methylocapsa, and Methylocystis 115 
genera that can use multi-compounds for growth in addition to methane (22-26). Also known 116 
today are filamentous methanotrophs from other genera, such as Crenothrix and Clonothrix, and 117 
non-proteobacterial (verrucomicrobial) methanotrophs of the genus Methylacidiphilum growing 118 
at high temperatures and low pH have also been discovered recently (27).  Finally, it was shown 119 
that Candidatus Methylomirabilis oxyferans, a member of the NC10 phylum, generates dioxygen 120 
for the oxidation of methane despite being an obligate anaerobe (28, 29).  Taken together, these 121 
data clearly illustrate the widespread nature of methanotrophic bacteria in most ecosystems of 122 
our planet. 123 
 124 
Physiology and biochemistry of methanotrophs 125 
Methanotrophs can use methane as an energy source, and also to provide carbon for all of their 126 
cellular constituents (6, 30, 31). The initial oxidation of methane to methanol is catalyzed by the 127 
enzyme methane monooxygenase (MMO). There are two structurally and biochemically distinct 128 
forms of MMO, a membrane-associated or a particulate MMO (pMMO), and a cytoplasmic or 129 
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soluble MMO (sMMO), which represent evolutionarily independent solutions to the same 130 
molecular problem of methane oxidation (32-37). The sMMO is a three-component binuclear 131 
iron active center monooxygenase that belongs to a large group of bacterial hydrocarbon 132 
oxygenases, known as soluble diiron monooxygenases (SDIMOs) (38), which are also 133 
homologous to the R2 subunit of class I ribonucleotide reductase. Two very similar sMMO 134 
systems, from Methylococcus capsulatus (Bath) (39-43) and Methylosinus trichosporium OB3b 135 
(44-47) have been studied in detail.  sMMO is encoded by a six-gene operon mmoXYBZDC and 136 
has three components: (1) a 250-kDa hydroxylase with an α2β2γ2 structure in which the α-137 
subunits (MmoX) contain the binuclear iron active center where substrate oxygenation occurs; 138 
(2) a 39-kDa NAD(P)H-dependent reductase (MmoC) with flavin adenine dinucleotide (FAD) 139 
and Fe2S2 prosthetic groups; and (3), a 16-kDa component (MmoB) known as protein B or 140 
coupling/gating protein that does not contain prosthetic groups or metal ions (39, 48).  There are 141 
X-ray crystal structures for the hydroxylase component (49-52), NMR-derived structures for 142 
protein B (39, 53, 54) and an NMR-derived structure for the flavin domain of the reductase (55).  143 
The complex formed by the three components has been studied structurally via small angle X-ray 144 
scattering analysis and biophysically by electron paramagnetic resonance spectroscopy, 145 
ultracentrifugation and calorimetric analysis (56, 57).  The catalytic cycle of sMMO has been 146 
extensively studied, and excellent progress has been made toward understanding the mechanism 147 
of oxygen and hydrocarbon activation at the binuclear iron center (45) (45, 58-62).  Detailed 148 
reviews of the structure and catalytic mechanisms of sMMO are available (6, 37, 47, 63, 64). 149 
 The pMMO, in contrast, is a copper- and possibly iron-containing, membrane-associated 150 
enzyme that is associated with unusual intracytoplasmic membranes that take the form of 151 
vesicular disks in type I methanotrophs and paired peripheral layers in type II organisms (65-75).  152 
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Intracytoplasmic membranes are enriched in pMMO and can be physically separated from the 153 
cytoplasmic membrane on the basis of sedimentation velocity in sucrose density gradients (76). 154 
An understanding of the structure and mechanism of pMMO has emerged more slowly than that 155 
of sMMO because of losses of activity when the enzyme is solubilized.  pMMO consists of three 156 
polypeptides of approximately 49, 27 and 22 kDa encoded by the genes pmoCAB (77).  There are 157 
often multiple copies of these pmo genes in methanotrophs (78, 79).  Recent studies have shown 158 
that native pMMO forms a complex with methanol dehydrogenase (MeDH), which may supply 159 
electrons to the pMMO (80, 81), similar to what has been found for the hydroxylamine 160 
oxidoreductase and ammonia monooxygenase redox couples (82-85). 161 
 Some methanotrophs such as M. capsulatus (Bath) and M. trichosporium OB3b can 162 
produce either form of MMO.  Most known methanotrophs possess only pMMO, e.g. 163 
Methylomonas methanica, Methylomicrobium album BG8, Methylocystis parvus OBBP, and the 164 
verrucomicrobial and NC10 methanotrophs.  Only a few methanotrophs within the 165 
Beijerinkiaceae family, e.g., Methylocella silvestris and Methyloferula stellata, have sMMO but 166 
do not possess pMMO (21, 86).   167 
 The methanol produced by MMO is oxidized to formaldehyde by a calcium or rare earth 168 
dependent pyrrolquinoline quinone (PQQ) containing MeDH (87-91).  Formaldehyde is an 169 
important branch-point in the metabolism of methanotrophic metabolism, and represents the 170 
point at which one-carbon (C1) intermediates can either be oxidized to CO2 to derive energy or 171 
assimilated into biomass.  Since formaldehyde is toxic, methanotrophs must protect themselves 172 
against accumulation of this metabolic intermediate. Multiple pathways for metabolism of 173 
formaldehyde are found in methanotrophs (2, 26, 92-96). For example, oxidative dissimilation of 174 
formaldehyde can occur by its conjugation to tetrahydromethanopterin (H4MPT) (97, 98), via 175 
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dye-linked membrane-associated (93) or via NAD+-dependent formaldehyde dehydrogenases 176 
(95, 96, 99).  Formate, resulting from the oxidation of formaldehyde by formaldehyde 177 
dehydrogenases, is further oxidized to carbon dioxide by an NAD+ -dependent formate 178 
dehydrogenase which generates NADH, which is then available for oxidation of methane, 179 
biosynthetic reactions, and energy generation within the cell (100-102).  Methanotrophs also 180 
possess two pathways for fixation of formaldehyde into biomass, the serine and ribulose 181 
monophosphate (RuMP) cycles active in Alphaproteobacterial and Gammaproteobacterial 182 
methanotrophs respectively. The pathways of carbon fixation in methanotrophs have been 183 
reviewed extensively (see e.g. (6)).   184 
 185 
The “copper-switch” in methanotrophs 186 
Early attempts to characterize methane oxidation were complicated by different reports on the 187 
cellular location of the MMO.  MMOs were described either as soluble or as membrane-188 
associated, depending on the strain and, for some strains, on the reporting laboratory.  Several 189 
groups initially reported activity in the particulate or membrane fraction (103, 104), whereas 190 
other groups detected activity in the soluble fraction (105, 106).  Subsequent studies showed the 191 
cellular location varied with cultivation conditions.  Oxygen-limitation was reported to induce 192 
methane oxidation in the soluble fraction in M. trichosporium OB3b (36, 107).  However, it was 193 
subsequently shown that oxygen was not the regulatory factor, and that the switch between the 194 
membrane-associated and soluble activity was related to biomass concentration (108).  The 195 
defining moment in the discovery of this “switch” was when Dalton and colleagues attempted to 196 
grow Methylocystis parvus OBBP to high cell densities in chemostat culture. They observed that 197 
cultures of M. parvus OBBP, when supplied with methane, air and a nitrate mineral salts solution 198 
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at relatively low cell densities, simply stopped growing. However, when additional trace 199 
elements solution was added, the cultures immediately started growing again. The “secret 200 
ingredient” in the trace elements solution was narrowed down to copper ions (108). It was 201 
subsequently realized that M. parvus OBBP contained only pMMO, hence the high requirements 202 
for copper ions, and did not contain a sMMO which would have allowed it to grow to the same 203 
high cell densities observed at the time with M. capsulatus Bath and M. trichosporium OB3b, 204 
under copper limitation.  The latter strains, when confronted with the same conditions, switched 205 
to expression of the sMMO and carried on growing (35, 109).  Interestingly, copper had earlier 206 
been shown to enhance growth of Methanomonas margaritae, a methanotroph which does not 207 
contain sMMO, but these original observations were never investigated further (110). 208 
 Dalton and colleagues followed up their observations in detail and established the 209 
existence of this “copper switch” i.e., the regulation of expression of the two different forms of 210 
MMO in methanotrophs in response to the copper-to-biomass ratio of cultures of methanotrophs 211 
which possess both sMMO and pMMO. This allowed them to explain many of the earlier 212 
observations on metal-dependent growth of methanotrophs. For instance, they showed that in M. 213 
capsulatus Bath, expression of the sMMO was only observed at high cell densities when copper 214 
ions in the medium were depleted, whereas additions of excess copper ions allowed this 215 
methanotroph to express active pMMO. Subsequently, Murrell and colleagues showed at the 216 
molecular level that under growth with low concentrations of copper ions, expression of sMMO 217 
was initiated at a σ54 promoter upstream of the sMMO gene cluster (mmoXYBZDC). Conversely, 218 
under high copper-growth conditions, expression of sMMO was repressed, and high levels of 219 
expression of the genes encoding pMMO (pmoCAB) allowed both M. trichosporium OB3b and 220 
M. capsulatus Bath to grow using pMMO (34, 111-113).  221 
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 Further research established that copper affects methanotrophic physiology and gene 222 
expression much more broadly. For example, it was found that the intracytoplasmic membrane 223 
content in methanotrophs increased with increasing copper in the growth medium (66, 109, 114). 224 
This was not totally unexpected, however: considering that the pMMO is localized in the 225 
intracytoplasmic membranes, then greater expression and activity of pMMO would logically 226 
require more of these membranes.  More surprisingly, however, it was recently discovered that 227 
pMMO and the PQQ-linked MeDH encoded by the mxa operon form a super-complex anchored 228 
in the intracytoplasmic membranes, and that electron transfer from the PQQ-linked MeDH to 229 
pMMO in vivo may drive the oxidation of methane (80, 81).  In support of this latter finding, it 230 
was recently found that not only does expression of pmo genes increase with increasing copper, 231 
but that of genes in the mxa operon does so as well (91).  232 
 It has also been shown by proteomics that additional steps in the oxidation of methane to 233 
carbon dioxide are overexpressed with increasing availability of copper, as that of proteins 234 
involved in lipid, cell wall, and membrane synthesis (66, 115).  Conversely, the ability of 235 
methanotrophs to direct carbon from methane to poly-3-hydroxybutyrate increases with 236 
decreasing copper availability (66, 116), suggesting that to some extent energy metabolism of 237 
methanotrophs is controlled by copper.  Such a conclusion was actually already reached earlier 238 
by Dalton and colleagues, who showed that the biomass yield and carbon conversion efficiency 239 
in methanotrophs when grown on methane increased as copper increased, i.e., when 240 
methanotrophs switch from expressing sMMO to pMMO (117).  Finally, it was found that the 241 
“surfaceome”, or proteins on the outer surface of the outer membrane, are also controlled by 242 
copper availability in some methanotrophs. The expression of several multi-c-type cytochromes 243 
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and proteins believed to be involved in copper uptake also vary, and in most cases decrease, as 244 
copper availability increases (118-123). 245 
 Recently, a new family of copper storage proteins, the Csps, have been discovered in M. 246 
trichosporium OB3b (124).  This bacterium possesses three Csps; Csp1 and Csp2 have predicted 247 
twin arginine translocase (Tat) targeting signal peptides and are therefore thought to be exported 248 
after folding, as well as the cytosolic Csp3. Csp1 forms a tetramer of four helix bundles that can 249 
bind up to 52 Cu1+ ions via Cys residues that point into the core of the bundle. Switchover to 250 
sMMO is accelerated in ∆csp1/csp2 compared to wild type suggesting that these proteins play a 251 
role in storing copper for the pMMO and provide an internal copper source when copper 252 
becomes limiting. Under such conditions mb is produced that can readily remove all Cu1+ from 253 
Csp1 and therefore may play a role in helping to utilize Csp1-bound copper. 254 
 255 
Evidence suggesting a copper-specific uptake system,  256 
The first evidence for a copper-specific uptake system and for the production of an extracellular 257 
copper-binding ligand came during the phenotypic characterization of constitutive sMMO 258 
mutants (sMMOC) of M. trichosporium OB3b (125, 126).  Phelps et al. (126) isolated five 259 
sMMOC mutants by culturing M. trichosporium OB3b in the presence of dichloromethane, acting 260 
as a mutagen following its co-metabolic transformation by methane monooxygenase to formyl 261 
chloride.  In addition to the sMMOC phenotype, sMMOC mutants were defective in copper 262 
acquisition (125, 127, 128). A drastic increase in soluble versus insoluble copper in the culture 263 
medium was also observed and fostered speculation on the production of an extracellular Cu2+-264 
complexing agent(s) analogous to Fe3+-complexing siderophores (128). Subsequent studies 265 
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revealed the presence of a low molecular mass copper binding ligand, although the identity of 266 
this compound was not determined (125, 127).   267 
 268 
Initial identification and isolation of methanobactin (a copper-binding compound or    269 
  “chalkophore”)       270 
 Somewhat paradoxically, the “copper-binding ligand” or “copper-binding compound” was 271 
first isolated from M capsulatus Bath during the purification of pMMO, and thus under 272 
conditions of high copper concentration (73). Separation of this copper-binding compound from 273 
the pMMO revealed a low molecular mass yellow fluorescence copper-containing molecule.  Its 274 
color and fluorescence properties of this molecule were similar to those of the water-soluble 275 
pigment observed in cells cultured in low copper medium (73).  Subsequent characterization of 276 
this water-soluble pigment revealed that it was identical to the copper-binding compound that co-277 
purified with the pMMO (73, 128).  The production of water-soluble pigments by methanotrophs 278 
had been noted during the initial isolation of many type strains over 40 years ago, but was 279 
associated with cells cultured in low iron medium (13).  The copper-binding compound was 280 
eventually termed methanobactin (mb), based on the molecule’s antimicrobial activity towards 281 
Gram-positive bacteria (129, 130). Once identified, this copper-binding compound was isolated 282 
or identified in a number of different methanotrophs, including Methylomicrobium album BG8 283 
(131), Methylocystis strain SB2 (132), Methylocystis rosea (133), Methylocystis hirsuta (133), 284 
and Methylocystis strain M (133).  In this review, we will focus on mbs whose primary structures 285 
have been determined from methanotrophs with sequenced genomes, i.e. M. trichosporium 286 
OB3b, Methylocystis strain SB2 and Methylocystis rosea. 287 
  288 
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Methanobactins as chalkophores 289 
Functionally, mbs are similar to siderophores.  Like siderophores, they are all low molecular 290 
mass (<1,200 Da) compounds produced by bacteria under low copper conditions (125, 126, 128, 291 
134-136).  Following the nomenclature of siderophores, which is Greek: iron-bearing or iron-292 
carrying, mbs are chalkophores, which is Greek: copper-bearing or copper-carrying (137, 138).   293 
Mbs are currently the only known representatives of this group.  Consistent with their role as the 294 
extracellular component of a copper acquisition system, mbs have some of the highest known 295 
binding affinities for copper ions (2, 130, 136, 139-141) (Table 1).  296 
 Although chalkophores and siderophores share a number of properties, these two groups 297 
of metal-binding compounds can be distinguished in a number of ways. With the exception of 298 
the phytosiderophore domoic acid (142), siderophores are expressed under iron limitation, 299 
whereas chalkophores are expressed under copper limitation.  Many siderophores bind copper, 300 
and chalkophores can bind iron (142-148), however, different metal binding constants 301 
characterize the two groups and colorimetric assays have been developed to distinguish between 302 
them based on this difference (136, 149, 150).  Structurally, chalkophores differ from 303 
siderophores by their typical heterocyclic rings and associated thioamide groups (Fig. 1 and 2). 304 
Different ring systems have characteristic UV-visible absorbance, circular dichroism (CD) and 305 
fluorescent spectral properties, which can be used for identification and to characterize the metal 306 
binding properties of the molecule (131, 133, 134, 136, 137, 141, 148, 151-153). Excitation 307 
energy transfer occurs between the two rings in mb (134, 154), as observed for the chromophores 308 
of light harvesting complexes (155-157), resulting in the fluorescent properties of mbs.  For 309 
example, the emission intensity of mbs increases with selective hydrolysis of the one of the 310 
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rings, and emission intensity often increases following metal addition (132, 134-136, 140, 148, 311 
154).  Again, this property can be used in both identification and characterization of mbs. 312 
 However, not all of the properties just described are sufficient to identify mbs. For 313 
instance, Clostridium cellulolyticum produces a copper binding secondary metabolite, 314 
closthioamide, with a molecular mass similar to mbs (158-160), and like mbs, closthioamide has 315 
thioamide groups, will reduce Cu2+ to Cu1+, and has a high Cu1+ binding affinity (>1015 M-1).  316 
Closthioamine will also test positive with the copper-chrome azural S (Cu-CAS) assay, a liquid 317 
or plate assay used to screen for mb production (136, 149, 161).  However, closthioamide can be 318 
distinguished spectroscopically from mbs, e.g. closthioamide shows a single UV-visible 319 
absorption maximum at 270 nm arising from its two characteristic phenolic groups separated by 320 
six thioamide moieties. Furthermore, closthioamide is able to form a dinuclear Cu1+ complex.  321 
Also in contrast to mbs, closthioamide synthesis is not regulated by copper, and unlike mbs, the 322 
molecule is believed to be produced by a polyketide synthase (see below). 323 
 Similarly, under low copper conditions, Paracoccus denitrificans also produces a low 324 
molecular mass 716.18 Da porphyin, coproporphyrin III, that appears to be involved in copper 325 
acquisition (162).  Unfortunately, the copper binding properties were not reported in the initial 326 
publication and we are not aware of any follow-up studies. Coproporphyrin III has a typical 327 
heme-UV-visible absorption spectra and shows different γ, α, β maxima depending on the metal 328 
coordinated by the heme group, allowing it to be distinguished from mb based on this property. 329 
 330 
STRUCTURAL PROPERTIES OF METHANOBACTINS 331 
Structural diversity and core features 332 
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The core features of all structurally characterized mbs are shown in Figs. 1 and 2.  As already 333 
mentioned above, mbs are modified peptides characterized by the presence of one oxazolone ring 334 
and a second oxazolone, imidazolone or pyrazinedione ring, which are separated by 2 – 4 amino 335 
acid residues  (see below, Biosynthesis of Methanobactin).  Each ring has an adjacent thioamide 336 
group.  Structurally, mbs can be divided into two types (Figs. 3 and 4).   One type (Group I) is 337 
represented by mb from M. trichosporium OB3b (mb-OB3b) (Figures 1A, 3A and 4).  In 338 
addition to these core properties, mb-OB3b also contains Cys residues in the mature peptide, 339 
which are linked by an intramolecular disulfide bond (Fig. 1A and 3A).  Cu1+-mb-OB3b has a 340 
pyramid-like shape with the metal coordination site at the base (133, 137, 141).  The disulfide 341 
bond is present in both apo- and Cu1+-mb-OB3b. Mb-OB3b is structurally the most complex mb 342 
characterized so far, and is currently the only structurally characterized representative of this mb 343 
type.  However, based on sequence similarity and alignments, the putative mbs from 344 
Methylosinus sp. strain LW3 (mb-LW3), Methylosinus sp. strain LW5 (mb-LW4), Methylosinus 345 
sp. strain PW1 (mb-PW1) and one of the two mbs from Methylocystis parvus OBBP (mb-346 
OBBP(1)) would also fall within this group (Fig. 4).  In this group the core peptide is predicted 347 
to contain 2 or more Cys in the mature peptide and/or to contain additional ring(s).  If the Cys are 348 
not incorporated into a ring, the second Cys and either the third or fourth Cys are predicted to 349 
form an intermolecular disulfide bond. 350 
 The second group (group II) is represented by mbs whose primary structures have been 351 
determined in Methylocystis rosea and Methylocystis strain SB2.  In this group, mbs lack the Cys 352 
residues in the mature peptide, are smaller and probably less rigid due to the absence of the 353 
disulfide bond found in mb-OB3b.  Heterocyclic rings are separated by two or three amino acids.  354 
In contrast to members of group II mbs from methanotrophic organisms, putative mbs from non-355 
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methanotrophs (mb-B-8, mb-14-3, mb-B510, mb-21721) contain four Cys in the apo-protein.  356 
However, based on the location of Cys residues, we predict all 4 Cys are incorporated in the two 357 
heterocyclic rings.  Mbs from the structurally characterized members in this group contain a 358 
sulfate group, which appears to aid in the formation of a tight bend in the molecule (Figs. 3B) by 359 
making a hydrogen bond with the backbone amide of Ser2. The sulfate group also increases 360 
affinity for copper ions (133).  Overall, mbs from the Methylocystis strains display a hairpin-like 361 
shape (Figs. 3B and 3C) (133).  The conserved T/S adjacent to the putative C- terminal ring 362 
suggest the other members of this group also contain a sulfate group (Fig. 4).  363 
 Truncated forms of mb have been identified for all structurally characterized mbs (133, 364 
136, 141), which results from the loss of one or more C-terminal amino acid residues (Figs. 1 365 
and 4.  The different forms show very similar copper binding properties (133, 141), but distinct 366 
reduction potentials (133, 141) and spectral properties (136).  The mechanism leading to the loss 367 
C-terminal amino acids remains an open question, but does not appear to involve N-protonation 368 
as observed for microcin B17 (163), since the C-terminal oxazolone ring of mb remains intact. In 369 
microcin B16, this reaction results in autoproteolysis of the ring and protein splicing.  In 370 
Methylocystis strains the sulfate group can also be lost, which does affect copper affinity (133). 371 
 Mbs thus have a number of unusual structural features.  Modifications of two residues to 372 
form oxazolone or imidazolone rings are rare, but have been observed in several classes of 373 
ribosomally-synthesized and post-translationally modified peptide (RiPP) secondary metabolites 374 
(163-166). Pyrazinedione rings are even more uncommon, and have only been detected in the 375 
non-amino acid containing molecules selerominol (167) and flutimide (168) from fungi.  The 376 
presence of thioamide groups in natural products is also rare and has only been identified in 377 
closthioamide from Clostridium cellulolyticum (160) and thioviridamide from Streptomyces 378 
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olivovirdis (169, 170).  Although rare, O-sulfonation of Ser or Thr have been reported in 379 
eukaryotic proteins (171), but to our knowledge mb is the only bacterial peptide that contains this 380 
post-translational modification and is ribosomally produced, as described below. 381 
 382 
Copper coordination site 383 
 In all mbs that have been structurally characterized, Cu1+ is coordinated in a similar 384 
manner by a N2S2 ligand set with a distorted tetrahedral geometry (Fig. 3) (133, 137, 141).  The 385 
C-terminal S- and N- ligands in the Methylocystis mbs are switched compared to their position in 386 
mb-OB3b (133), however, the resulting coordination geometry is very similar.  The coordination 387 
sites are stabilized by the two 5-membered chelate rings formed upon ligation and a number of 388 
hydrogen bonding and π-interactions (Fig. 3), for example between the backbone amide of Cys3 389 
and a coordinating sulfur in Cu1+-mb-OB3b and a π-anion interaction between the sulfate and the 390 
pyrazidione ring in Methylocystis mbs (133, 141). 391 
 392 
METAL BINDING PROPERTIES 393 
Binding and reduction of the primary metal– copper 394 
Mb binds both Cu2+ and Cu1+ and the binding by mb appears to depend on pH (141, 172) and on 395 
the Cu2+/Cu1+ to mb ratio (134, 140, 172) (Table 1).  As discussed below, mb is able to complex 396 
both soluble and insoluble forms of Cu1+ and Cu2+.  Thermodynamic, spectral and kinetic studies 397 
have been carried out on the addition of Cu2+ to mb-OB3b and Methylocystis strain SB2 (mb-398 
SB2) (134, 140). These studies (134, 140, 172) are complicated by the fact that mb rapidly 399 
reduces of Cu2+ to Cu1+.  Since the oxidation state of copper responsible for the high bonding 400 
constant for experiments in which Cu2+ has been added to apo-mbs is not known, we will 401 
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indicate that a mixture of these oxidation states is present using Cu2+/Cu1+ from this point on. At 402 
low Cu2+/Cu1+ to mb-OB3b ratios, mb-OB3b initially binds Cu2+/Cu1+ as an oligomer/tetramer 403 
(134, 140).  Pre-steady state kinetic data also suggest that the initial binding of metal is only on 404 
one of the rings and its associated thioamide.  In mb-OB3b, initial Cu2+/Cu1+ coordination is to 405 
the oxazolone A, followed by a short (8 – 10 ms) lag period and then coordination to oxazolone 406 
B (140).  At higher Cu2+/Cu1+ to mb-OB3b ratios, mb-OB3b coordinates Cu2+/Cu1+ as a dimer 407 
followed by a monomer at Cu2+/Cu1+ to mb-OB3b ratios above 0.5 Cu2+ per mb-OB3b.  Mb-SB2 408 
appears to follow a similar tetramer-dimer-monomer binding sequence depending on the copper 409 
to mb ratio.  For mb-SB2, the initial binding of Cu2+/Cu1+ is to the imidazolone ring followed by 410 
coordination to the oxazolone ring (154).   411 
 A number of different methods have been used to determine metal binding affinity 412 
constants for mbs (Table 1). Affinities for Cu1+ can be determined from competition studies 413 
using a well established approach (173-175) with chromophoric ligand such as bathocuproine 414 
disulfonate. The measurement of the reduction potential of the Cu-mb then allows the Cu2+ 415 
affinity to be calculated.  The Cu1+ affinity is ~1021 M-1 for all mbs analyzed using this approach 416 
(133, 141), and is one of the highest known for biological systems.  Such a high affinity raises 417 
the issue of how copper is released from mb within a methanotroph. The reduction of the 418 
disulfide, in mb-OB3b (141), and removal of the sulfate, in Methylocystis mbs (133), do 419 
decreases the Cu1+ affinity by ~2 order of magnitude, but the values are still high.  Given that the 420 
Cu2+ affinities are significantly weaker (Table 1) oxidation may be utilized for release of the 421 
metal, which may be more likely for those Cu-mbs with lower reduction potentials, such as Cu-422 
mb-CSC1 (133).   423 
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 Other copper chelating compounds, primarily for Cu2+, have also been used to estimate 424 
affinities (91, 125, 128, 133, 141), as well as isothermal titration calorimetry (134, 140), and 425 
displacement isothermal titration calorimetry (134) (Table 1).  Mbs have been shown to 426 
solubilize and bind insoluble forms of Cu1+ under anaerobic conditions (140), and to extract Cu 427 
from copper minerals (176), humic material (177), and glass (178).  The ability of mbs to extract 428 
copper from copper-containing minerals as well as other organic molecules should be considered 429 
in modeling bioavailable sources of copper (179-183).  430 
 431 
Binding of other metals 432 
In addition to copper, mb-OB3b and mb-SB2 have been shown to bind a number of transition 433 
and near transition metals (135, 148, 154, 184)(Table 1).  In general, the spectral properties 434 
following binding are unique for each metal, and can be used in initial analysis of metal binding 435 
and in metal competition studies (135, 154). The primary function of mbs appears to be copper 436 
acquisition and the capacity to bind other metals appears to be an inadvertent consequence of the 437 
Cu1+-coordination site.  The peptide backbone of mbs appears to influence the binding of other 438 
metals.  For example, the order of metal binding preference by mb-OB3b is Cu2+/Cu1+ = Hg2+ = 439 
Au3+ > Zn2+ > Cd2+ > Co2+ > Fe3+ > Mn2+ > Ni2+, where as the metal binding preference for mb-440 
SB2 is Au3+ > Hg2+ > Cu2+/Cu1+ > Zn2+ > Cd2+ = Co2+ = Fe3+ > Mn2+ > Ni2+ (135, 154). 441 
 Although strong binding of other metals such as mercury by mbs may seem counter-442 
productive for methanotrophic growth, it may actually be of some benefit. Specifically, by 443 
strongly binding mercury, mbs may significantly alter its speciation and bioavailability, thereby 444 
reducing its toxicity. Indeed, growth studies showed that in the presence of mercury, added as 445 
mercuric chloride, methanotrophic growth was completely inhibited, but growth did occur when 446 
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mb was also added (184).  Interestingly, such a protective effect was seen in a variety of 447 
methanotrophs when exposed to mercury and mb-OB3b.  These results suggest mb secreted by 448 
any methanotroph could serve to protect the broader microbial community from mercury toxicity 449 
(184).   450 
 Further indirect evidence of the importance of mb binding to metals other than copper 451 
was afforded by the observation that in M. trichosporium OB3b sMMO is expressed and active 452 
in the presence of both gold and copper. This finding was unexpected since, as discussed above, 453 
copper strongly represses expression of sMMO.  Also, the amount of copper associated with 454 
biomass significantly decreased in the presence of gold, as compared to when gold was not 455 
added (91).  This suggests that mb-OB3b is limited in its ability to bind copper in the presence of 456 
gold. Indeed, if mb was pre-loaded with copper and added exogenously to M. trichosporium 457 
OB3b, sMMO expression was not observed, and copper levels associated with biomass increased 458 
(91).  These findings suggest that although methanotrophs synthesize mb for copper uptake, such 459 
uptake may be compromised if other metals such as gold are also present due to their ability to 460 
compete effectively for binding to mb.  These observations suggest that in such situations, 461 
sMMO may be expressed and active even in the presence of copper, which may alter the 462 
methanotrophic community structure as well as activity. 463 
 464 
Metal reduction   465 
 As mentioned above, another property exhibited by all mbs examined so far is their 466 
ability to reduce Cu2+ to Cu1+ (133, 134, 140, 141, 185).  In addition, mb-OB3b and mb-SB2 467 
have also been shown to reduce Au3+ and Ag+ to Au0 and Ag0, respectively (135, 148).  In the 468 
case of gold, no other oxidation states were observed. In contrast, no change in the oxidation 469 
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states of Zn2+, Cd2+, Co2+, Fe3+, Mn2+, and Ni2+ was observed following binding by mb-OB3b 470 
and mb-SB2 (135, 148). Surprisingly, in the absence of an external reductant, both mb-OB3b and 471 
mb-SB2 have been shown to reduce multiple Cu2+ and Au3+ ions, which raise the question of the 472 
electron donor for this reaction. 473 
 474 
BIOSYNTHESIS OF METHANOBACTIN 475 
Identification of the polypeptide precursor of methanobactin 476 
Although a potential peptide sequence precursor of mb-OB3b was identified following 477 
hydrolysis of the oxazolone rings (132), the question whether this peptide was assembled by a 478 
non-ribosomal peptide synthetase or encoded by DNA and synthetized on the ribosome 479 
remained.  Determination of the genome sequence of M. trichosporium OB3b helped resolve this 480 
question. BLAST searches using the predicted mb peptide precursor revealed a short ORF with a 481 
perfect match at a location within the M. trichosporium OB3b genome sequence where no 482 
protein product had been predicted (Fig. 4). The genome region of the putative mb precursor 483 
matching sequence in M. trichosporium OB3b had a number of distinctive and striking features 484 
(Fig. 5; Table 2). These included (a) a precursor peptide composed of leader and core peptide 485 
sequences followed by a stop codon, as expected for post-translationally modified peptide 486 
natural products (164); (b) a potential cleavage site between the leader and core peptide, 487 
suggestive of secretion; (c) genes upstream and downstream of the mb precursor gene encoding 488 
protein sequences compatible with possible roles in maturation of the mb precursor sequence, 489 
transport, and regulation of mb biosynthesis (Fig. 5, Table 2). 490 
 Elaboration on this initial search revealed a series of genomes containing gene clusters 491 
with characteristics matching that of the M. trichosporium OB3b mb gene cluster, e.g. in 492 
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Methylocystis parvus OBBP (139, 186, 187), Methylosinus sp. LW3 (186), as well as non-493 
methanotrophs Azospirillum sp. B510 (132, 139), Azospirillum sp. B506 (186), Pseudomonas 494 
extremaustralis (139), Pseudomonas extremaustralis substrain laumondii TT01 (186), Tistrella 495 
mobilis (139), Gluconacetobacter sp. SXCC (132, 186). Gluconacetobacter oboediens (186, 496 
187) Methylobacterium sp. B34 (186) ,Cupriavidus basilensis B-8 (186), Photorhabdus 497 
luminescens (186) and Vibrio caribbenthicus BAA-2122 (186).  Notably, this list not only 498 
includes methanotrophic strains known to produce mb for which a genome sequence was 499 
available, but also in the genome of other strains, suggesting that such gene clusters may encode 500 
peptide-derived products with more diverse functions than those associated with mbs.  501 
Considering the mb precursor peptides identified so far, it is striking that the leader peptides are 502 
much more strongly conserved than core peptide sequences (Fig. 4).  It is also interesting to note 503 
that sequence conservation does not follow taxonomic affiliation, and that identical precursor 504 
sequences are found in gene clusters of strains from different genera (Fig. 4). This strongly 505 
suggests that horizontal gene transfer has contributed to dissemination of mb gene clusters in the 506 
environment, and indeed, mobile genetic elements have often been identified in the sequences 507 
immediately adjacent to mb gene clusters (186).  508 
 The lack of sequence conservation in mb core peptides also implies that designing 509 
sequence motifs to detect mb gene clusters is challenging, and that database hits using sequence 510 
motifs based on known mb precursor sequences need to be substantiated with other evidence. In 511 
our view, for a sequence hit to be considered indicative of a mb precursor, additional evidence 512 
should include (a) the presence of the only conserved genes in the mb gene cluster (Fig. 5), i.e. 513 
the genes for mb biosynthesis cassette proteins MbnB and MbnC, in the immediate vicinity of 514 
the mb peptide precursor; and (b), the presence of 2 or more cysteines in the core mb peptide 515 
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sequence (Fig. 4; Table 2). Regarding the latter, it is striking that mb peptide precursors 516 
identified so far contain either 2 or at least 4 cysteines, just as in the two types of mbs 517 
characterized so far. Nevertheless, the spacing between cysteine residues in the mb peptide 518 
precursor sequence appears to be quite variable, with 1 or 2 residues between the first and the 519 
second cysteine, and if present, 2-4 residues between the second and the third cysteine, and 1-3 520 
residues between the third and the fourth cysteine, respectively (Fig. 4). It is also striking to note 521 
that “doublets” of two cysteine residues immediately adjacent to each other have only been 522 
found so far in putative mb precursor peptides of presumably non-methanotrophic strains (Fig. 523 
4). 524 
 The overall structure of mb gene clusters and related gene clusters is beyond the scope of 525 
this review, but their analysis, using a combination of sequence-based, motif-based and gene 526 
synteny-based searches, will undoubtedly yield many interesting findings in the future, as more 527 
mb gene clusters are identified in the increasing number of microbial genomes that are being 528 
sequenced.  Summarizing the quite large diversity of mb gene clusters that have already been 529 
detected (see e.g. Kenney and Rosenzweig (186)), two major types of mb gene clusters seem to 530 
emerge with respect to the localisation of the mbnA gene for the mb precursor peptide (Fig. 5). 531 
Whereas mbnA is always directly upstream and in the same orientation of mbnB and mbnC, it 532 
may be found as a short orf, as exemplified for strain OB3b (Fig. 5), or actually represent the 3’-533 
end of regulatory gene mbnI, as in strains SB2 and SV97 (Fig. 5).  The implications of the latter 534 
localization of the mbnA gene, notably in terms of regulation of mb expression in strains with 535 
this gene arrangement (also see Regulation of Gene Expression Section below), are completely 536 
unknown at present.  Currently, the cytochrome c peroxidase MbnH (Fig. 5; Table 2), as well as 537 
the FAD-dependent oxidoreductase MbnF, present instead or sometimes in addition to MbnH in 538 
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methanotroph gene clusters (186, 187) are likely candidates to be involved in the oxidation steps 539 
required for ring formation (see below, and Fig. 6). In addition, the aminotransferase MbnN 540 
found in the mb-OB3b, but not the mb-SB2 gene cluster (Figure 5) may be involved in formation 541 
of the N-terminal keto-isopropyl group from Ile1 in the peptide precursor, and the 542 
sulfotransferase MbnS found in the mb-SB2 and mb-rosea, but not the mb-OB3b gene cluster 543 
may catalyse sulfonation of the threonine (see Fig. 1 and 5). Two other gene products, TonB 544 
receptor, multidrug and toxin extrusion (MATE) protein, Fig. 5; Table 2) have been suggested 545 
(186, 187) to be involved in uptake and secretion of mature mbs, respectively.  The reader is 546 
referred to a recent review by Kenney and Rosenzweig (186) for a detailed description and 547 
phylogenetic analysis of several mb gene clusters. 548 
 549 
Current hypotheses on the nature of the mb biosynthesis pathway 550 
Despite the identification of the genetic determinants of mb production, the precise mechanism 551 
involved in maturation of mbs from peptide precursors still represents an open question.  The 552 
presence of heterocyclic rings would suggest a pathway similar to that of other post-ribosomal 553 
peptide synthesis (PRPS) proteins (163-166, 188).  For instance, in the PRPS protein microcin 554 
B17, McbB (cyclodehydrase), McbC (FMN-dehydrogenase) and McbD convert  –Gly-Cys- and  555 
–Gly-Ser-dipeptide sequences into thiazole and oxazole rings, respectively (163).  In this 556 
reaction sequence, the cyclodehydrase catalyzes ring formation via the amine bond with the thiol 557 
or alcohol, followed by oxidation by an FMN-dehydrogenase (163-166).  In mb, ring formation 558 
is initiated from an –X-Cys-dipeptide sequence, resulting in formation of either an oxazolone, 559 
imidazolone or pyrazinedione ring with a neighboring thioamide group.  If the catalytic sequence 560 
in ring formation in mb followed the microcin B17 example, the thiol group on Cys from mb 561 
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would have to be replaced by a hydroxyl group, possibly with an amine intermediate.  Then the 562 
thioamide group would have to be introduced via an amide to thioamide replacement, as 563 
proposed for two other natural products with thioamide groups (153), closthioamide from 564 
Clostridium cellulolyticum (160) and thioviridamide from Streptomyces olivoviridis (169, 170).  565 
As an alternative, the thioamide group of mbs was proposed to originate from the Cys thiol, as 566 
hydrolysis of the oxazolone rings resulted in a -X-Gly-thioamide sequence (132).  Based on the 567 
precursor peptide sequences that have now been identified, the latter reaction mechanism now 568 
appears highly likely. 569 
 The absence of a cyclodehydrase-like gene in mb gene clusters also suggest that ring 570 
formation differs from that of other natural products in other aspects as well. The simplest and 571 
shortest reaction sequence in oxazolone ring formation in mbs would involve an oxidation 572 
followed by a rearrangement that changes the connectivity of the peptide backbone (Fig. 6). In 573 
such a scheme, Cys thiols would likely require to be protected against oxidation (blue circle), as 574 
protein-linked thioesters, or alternatively as disulfides (as shown in Fig. 6), possibly via 575 
glutathionylation as observed with MetE in Escherichia.coli (189).  This reaction may occur 576 
during the initial peroxidase reaction, which is one of the proteins of the mb gene cluster (Table 577 
2).  The reaction sequence could operate during formation of both oxazolone rings of mb-OB3b, 578 
from Leu1 and Cys2, and from Pro7 and Cys8 of the precursor peptide, respectively.  579 
Methylocystis strain SB2 and M. rosea share the same mb gene clusters and identical precursor 580 
peptides (Figs. 4 and 5), but the mature mb of Methylocystis strain SB2 (132) as characterized 581 
contains an imidazolone ring, whereas the mb from M. rosea has a pyrazinedione ring that is also 582 
present in the Methylocystis strain M mb (133).  However, imidazolone and pyrazinedione rings 583 
are actually isomeric and can be interconverted by a simple sequence of hydration, 584 
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rearrangement, and dehydration reactions (190). Nevertheless, the mechanism of formation of 585 
this ring is likely to be more complex than that for oxazolone ring formation (Fig. 6).  One 586 
possible sequence would replace the transamination reaction, proposed for mb-OB3b, with an 587 
oxidative deamination of the N-terminal amine, which would produce ammonia that could be 588 
used for subsequent aminolysis of the oxazolone ring (Fig. 6). A condensation reaction would 589 
then lead to cyclization and the formation of the imidazolone, or with an intervening 590 
rearrangement step, to the pyrazinedione. It should be noted that the Methylocystis species lack 591 
the aminotransferase found in the mb-OB3b gene cluster. Alternate reaction schemes would 592 
involve two changes of connectivity in the peptide backbone, and not just one as proposed for 593 
oxazolone ring formation (Fig. 6). Clearly, the formation of the different types of heterocyclic 594 
ring systems in mbs now needs to be addressed experimentally. The production and 595 
characterization of mutants will hopefully help in this respect, and such studies have now been 596 
initiated (187).  597 
 598 
REGULATION OF GENE EXPRESSION   599 
The discovery of the mb biosynthesis gene cluster raised two main questions. First, is mb 600 
biosynthesis regulated with respect to copper?  Second, what is the role of mb in the “copper-601 
switch” controlling the expression of the two forms of MMO? The first question was easily 602 
answered through the use of reverse-transcription-quantitative polymerase chain reaction (RT-603 
qPCR) using primers specific to some gene(s) of the mbn operon.  Initial studies found that in M. 604 
trichosporium OB3b, expression of mbnA, the gene encoding the polypeptide precursor of mb, 605 
did indeed vary with respect to copper, with expression dropping over three orders of magnitude 606 
when copper concentrations increased from zero (no amendment) to 1 µM copper, and 607 
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expression was largely invariant at higher copper concentrations (139).  Such a decrease in 608 
expression was reflected in the finding that mb in the spent medium was highest at copper 609 
concentrations less than 1 µM, and dropped ~5-fold when the copper concentration was 610 
increased to 5 µM (134, 136, 140).  Given that the two forms of MMO are also regulated by 611 
copper, it was possible that mb was directly involved in this copper-switch. Further genetic 612 
analyses, however, found that it is not (139).  RT-qPCR of mmoX and pmoA from both M. 613 
trichosporium OB3b wild type and a mbnA mutant where a gentamycin cassette was inserted, 614 
knocking out mbnA, showed that mmoX and pmoA expression followed similar patterns in both 615 
strains as the copper-biomass ratio varied, but that the magnitude of such changes were lower in 616 
the mbnA::GmR mutant as compared to the wild type strain (139).  To answer the second 617 
question above, another mutant was constructed in which the mmo operon was deleted. In this 618 
mutant the “copper-switch” was inverted, i.e., pmoA expression was greatest in the absence of 619 
copper, and dropped ~two orders of magnitude when copper concentrations increased (139).  620 
Further, expression of mbnA was largely invariant in this mutant with respect to copper.  Since 621 
all deleted genes in the mmo operon with the exception of mmoD are known to encode 622 
polypeptides of sMMO, and since MmoD is not required for sMMO activity (32, 51, 63), these 623 
expression data suggest that MmoD is a key component of the copper-switch, MmoD serving to 624 
regulate expression of mb, and mb then amplifying the magnitude of the response in the copper 625 
switch.   626 
 On the basis of these findings, a model for the regulation of expression of the mmo and 627 
pmo operons by mb and MmoD was proposed (139).  During growth at low copper : biomass 628 
ratios, MmoD protein represses expression of the pmo operon and also up-regulates expression 629 
of the mmo operon, including that of mmoR and mmoG shown previously to play key roles in 630 
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regulating mmo expression (113).  Further, MmoD is postulated to enhance expression of mb, 631 
which serves to amplify expression of the mmo operon.  During growth under high copper, mb 632 
binds copper and can no longer enhance the expression of the mmo operon. Under these 633 
conditions, it is presumed that MmoD also binds copper and no longer represses expression of 634 
the pmo operon or induces expression of sMMO or mb.   635 
 There are, however, a number of issues with the model as proposed in Fig. 7. For such a 636 
model to be accurate, mmoD would be required to be constitutively expressed with respect to 637 
copper, in order for sMMO and mb expression to occur after copper is removed.  This version of 638 
the model implies, however, that as copper : biomass ratio increases, expression of the entire 639 
mmo operon no longer occurs. Recent qRT-PCR analysis, however, show that mmoD, unlike 640 
mmoX, is constitutively expressed with respect to copper (Semrau, unpublished data). 641 
Nevertheless, expression of mmoD, as that of mmoX, increases with increasing addition of 642 
exogenous mb, suggesting that expression of mmoD is at least partly co-regulated with that of the 643 
entire mmo operon.  644 
 In addition, this model, although explaining the genetic basis for the copper-switch in 645 
methanotrophs, does not explicitly consider the role of two genes known to play roles in the 646 
regulation of the mmo operon, i.e., mmoR and mmoG upstream of mmoX (113, 191).  Based on 647 
available data, it appears that mmoR and mmoG do not play a significant role in the copper-648 
switch, i.e., they do not appear to have any control over expression of the pmo operon.  It is 649 
possible, however, that regulation of the mmo operon is the result of a concerted interaction of 650 
mb and/or MmoD with these gene products.   651 
 This model also ignores the possibility that the presence of putative regulatory genes (e.g. 652 
mbnI and mbnR, Fig. 5) in mb gene clusters, which may play a role in regulating gene 653 
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expression, particularly the mb gene cluster and/or the mmo operon. Given this, a revised model 654 
of the copper-switch in methanotrophs is now proposed in Fig 8.  Here MmoD is again 655 
postulated to be a key component of the copper switch, but MbnI is proposed to be responsible 656 
for inducing expression of the mb gene cluster, as well as mmoR and mmoG.  Collectively, mb, 657 
MmoR and MmoG interact to induce expression from the σN promoter upstream of mmoX, while 658 
MbnI binds to the σ70 promoter upstream of mmoY.  In this updated and revised current model, 659 
mmoD is constitutively expressed, but associates with copper when it is present, preventing 660 
repression of the pmo operon or expression of the mb gene clusters.  Further experiments will 661 
show whether this new model is correct, but it is already clear that the exact details of the copper 662 
switch mechanism are more complex than previously thought. 663 
 664 
PHYSIOLOGICAL FUNCTION(S) 665 
Copper acquisition  666 
 Although mb has a high affinity for copper, its importance in copper acquisition by 667 
methanotrophs is still unclear.  Non-native Cu1+-mbs have been shown to be taken up by 668 
methanotrophs and facilitate switchover to pMMO (133). Copper uptake and switchover is faster 669 
if the native mb is used, but still takes more than 24 hours.  However, the role of mb in meeting 670 
the overall copper requirements of the cell is still in question. It has been found that M. 671 
trichosporium OB3b possesses at least two mechanisms for copper uptake, the first one clearly 672 
based on mb and involving active transport of copper-mb complexes and another, non-specific 673 
passive transport pathway (192).  It was also found that the amount of copper associated with 674 
biomass was the same regardless of whether copper was added as CuSO4 or as the Cu1+-mb 675 
complex at the same concentration.  Subsequently, it was found for M. trichosporium OB3b that 676 
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when the gene for the precursor polypeptide of mb (mbnA) is knocked out, copper is still 677 
associated with biomass, and increases with increasing amounts of copper in the growth medium 678 
as does copper found associated with wild type cultures.  The role of mb in copper uptake thus 679 
remains unclear. It should be kept in mind that these studies were performed using well-defined 680 
growth medium with limited diversity of copper speciation and little if any copper-containing 681 
precipitates.  It is tempting to speculate that mb may have a more significant role in copper 682 
uptake in situ, where copper speciation and distribution will be much more complex, and will 683 
include copper associated with a wide range of organic materials (e.g., humic and fulvic acids), 684 
as well as found either sorbed onto or part of various mineral phrases.  Indeed, it has been shown 685 
that expression of pmoA is strongly dependent on the form of copper present, with copper 686 
associated with metal oxides found to induce smaller changes in pmoA expression, and that 687 
concomitant addition of mb increased the magnitude of the copper switch in M. trichosporium 688 
OB3b (176, 193).   689 
 690 
Methanobactins: a role as signaling molecules? 691 
Given the small size of mbs, and their secretion into the environment when copper availability is 692 
low, a role for mbs as signaling molecules may be envisaged.  Indeed, addition of mb-OB3b 693 
enhances expression of mmoX in in cultures of both wild type M. trichosporium OB3b and its 694 
mbnA::GmR mutant (187) (139, 184), suggesting that mb may control gene expression by acting 695 
as a signaling molecule. Further, given that all known forms of mb have significant structural 696 
similarity, mbs may allow for cross-species communication.  Recent studies show that this is 697 
indeed the case.  Mb-SB2 increased both mmoX expression and sMMO activity in M. 698 
trichosporium OB3b in the presence of copper.  However, it had no significant effect (P > 0.05) 699 
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on expression of either pmoA or mbnA, nor did it increase the amount of cell-associated copper 700 
(91). The addition of mb-SB2 preloaded with copper, however, reduced both mmoX and mbnA 701 
expression when M. trichosporium OB3b was grown in the absence of any added copper, and no 702 
sMMO activity was detected.  These latter results were likely due to the increased amount of 703 
cell-associated copper, and may reflect the role of mb in copper uptake. 704 
 705 
Membrane development 706 
Several studies have demonstrated a direct correlation between intracytoplasmic membrane 707 
development and expression of pMMO in methanotrophs (33, 35, 66, 109, 114, 194).  As stated 708 
above, mbnA plays a secondary role in the regulation of both the membrane bound and soluble 709 
MMO (see Regulation of Gene Expression).  However, deletion of mmoD along with the rest of 710 
the sMMO operon, had little effect on intracytoplasmic membrane development in M. 711 
trichosporium OB3b (Fig. 9C and 9D).  In contrast, a deletion mutation in the mbnA structural 712 
gene for mb, appears to effect intracytoplasmic membrane development well beyond its effects 713 
on pMMO expression (187) (Figs. 9E and 9F).  Currently, the effect(s) of mb on 714 
intracytoplasmic membrane development is observational, and additional research is required to 715 
determine whether mb is directly involved in the development of these membranes in 716 
methanotrophs.  717 
 718 
Detoxification of reactive oxygen species   719 
Copper is one of the essential metals required by microorganisms for growth (179).  Like iron, 720 
however, copper in oxygenated solutions can generate a variety of toxic reactive oxygen species 721 
via Fenton and Haber-Weiss reactions (195-197).  The coordination of copper by mb is likely to 722 
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reduce this toxicity, as observed with the iron and copper-binding siderophore, schizokinen 723 
(146). Nevertheless, both copper-bound and copper-free forms of mb-OB3b have been shown to 724 
reduce dioxygen to superoxide in the presence of a reductant (198). In general, this would 725 
represent a daunting problem for bacteria that accumulate high concentrations of Cu-mb.  726 
Perhaps not unexpectedly, the superoxide dismutase (SOD) activity of Cu-mb is approximately 727 
30,000 times higher than the oxidase activity associated with either mb-OB3b or Cu-mb-OB3b.  728 
In addition, in the presence of a reductant, Cu-mb-OB3b also has a hydrogen peroxide reductase 729 
(HPR) activity which is approximately 50 times the oxidase activity (198).  The overall result of 730 
these three activities is the reduction of O2 to H2O with concomitant loss of reductant.  In 731 
addition to their protective roles in the context of mb catalyzed oxidations, high SOD and HPR 732 
activities of mb are also likely to provide protection against oxygen radicals that are potentially 733 
formed during methane oxidation and respiration of dioxygen (196, 199, 200), and may thus 734 
explain the stabilizing effects of mb-OB3b on pMMO activity in cell free extracts (66, 73, 198).  735 
Similar activities have also been observed for mb-SB2 (Bandow et al., unpublished results), and 736 
we predict this is a property of all mbs. 737 
  738 
MEDICAL, INDUSTRIAL AND ENVIRONMENTAL IMPLICATIONS 739 
Metal mobilization or immobilization for remediation of polluted subsurface environments.   740 
Based on the published yields of mb in laboratory cultures (134, 136), methanotrophs are 741 
predicted to export 3 – 50 copies of mb per cell per second depending on the copper 742 
concentration during growth.  Given this high export rate, and the fact that mb can bind most 743 
transition and near transition metals, it is likely that mb is able to influence metal mobilization 744 
and thus bioavailability of different metals in soil systems, and that this affects the structure and 745 
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functioning of microbial communities. Recent studies have shown that mb will bind both 746 
inorganic and organic forms of mercury (154) and thereby protect the host bacterium as well as 747 
other bacteria from mercury toxicity (184).  However, additional studies are required to answer 748 
which metals are affected in their mobility by mbs, and the effects of mbs on the soil microflora. 749 
 750 
Formation of gold nanoparticles  751 
The potential application of gold nanoparticles as anti-inflammatory agents, in the targeting of 752 
cancer cells, detection of melamine, as biosensors, and in glucose oxidation has motivated the 753 
development of various production methods for such materials (201-206).  Most approaches 754 
require either high (> 100°C) or low (-18°C) temperatures in the presence of reducing and 755 
stabilizing agents.  Alternatively, microbially-mediated production of gold nanoparticles, both 756 
intracellularly and extracellularly, has also been extensively investigated (207).  However, the 757 
size distribution of gold nanoparticles produced by microbial processes is usually quite broad, 758 
ranging in size from 10-6000 nm (208). Further, most reported processes yield particles with a 759 
wide variety of shapes (spherical, octahedral, triangular, irregular, etc.), and rates of formation 760 
vary over a large range, from minutes to hours (209).  Crucially, both mb-OB3b and mb-SB2 761 
have been shown to efficiently reduce Au3+ ions to metallic gold (typically >5 ions/mb), and in 762 
so doing to form well-defined size distributions of spherical nanoparticles (135, 148).  In a 763 
further study with mb-SB2, gold spherical nanoparticles of well-defined sizes, 2.0 ± 0.7 nm, 764 
were formed, with mb-SB2 suggested to act both as a reductant and as a stabilizing agent, 765 
thereby demonstrating that use of mb-SB2 represents a viable approach to produce well-defined 766 
gold nanoparticles in this size range (135).  767 
  768 
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Possible therapeutic treatment of human ailments   769 
Copper has been implicated as a key factor in the development of a variety of human ailments, 770 
perhaps most notably Wilson’s disease (210, 211), in which affected individuals have mutations 771 
that inactivate the Cu-transporting P-type ATPase ATP7B (212) impeding copper export to the 772 
bile, and causing copper accumulation in the liver.  Based on in vivo and in vitro studies, copper 773 
accumulation specifically affects liver mitochondria, via copper-induced modification of 774 
membrane protein thiols leading to multiprotein cross-linking (213). In the final stages of 775 
Wilson’s disease, oxidative damage, primarily in the liver, is observed.  Other symptoms of 776 
Wilson’s disease include serious neurological issues that can lead to additional psychiatric 777 
disorders (210, 214, 215).   778 
 There is as yet no cure for Wilson’s disease. Currently, treatment consists of one or more 779 
of the following options: (1) the use of chelating agents to remove copper via enhanced urine 780 
excretion; (2) implementation of a low copper diet, and (3) zinc supplements added to the diet to 781 
stimulate production of the copper binding protein metallothionein (210, 214).  Of these options, 782 
the use of chelating agents is the most commonly prescribed treatment, with two drugs, 783 
penicillamine and trientine, currently approved by the US Food and Drug Administration (FDA).  784 
Penicillamine, a breakdown product of penicillin, binds copper (216) and also induces the 785 
production of metallothionein.  Although the clinical benefit of penicillamine is widely reported, 786 
it has serious side effects including bone marrow suppression, degeneration of elastic tissue, and 787 
proteinuria. In a large fraction of cases (20-50%), neurological deterioration is observed (217).  788 
In such cases, the polyamine trientine, which has fewer reported side effects compared to 789 
penicillamine (218), and a comparable if not higher affinity for copper (135), is substituted.  In 790 
both penicillamine and trientine treatments, copper is excreted through the urine and not the bile.  791 
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Another chelating agent, tetrathiomolybdate, allows for copper to be excreted from liver 792 
primarily into the blood, but some evidence suggests that part of the copper may also be 793 
transferred to the bile (219), and that insoluble copper is found in both liver and kidneys at 794 
tetrathiomolybdate:copper ratios greater than two (219-221).  It is unclear what the physiological 795 
impact of such an increased burden of copper in the blood, as well as the formation of insoluble 796 
copper.   797 
 Mbs may represent a superior alternative as a copper chelating agent to treat Wilson’s 798 
disease, as indicated by preliminary studies.  In the animal model for Wilson disease, the Long 799 
Evans Cinnamon (LEC) rat, intravenous application of mb-OB3b extracted copper from the liver 800 
into the bile as Cu-mb-OB3b, without measurable side-effects (213, 222).  It was also found that 801 
mb-OB3b reversed both the buildup of copper in liver mitochondria and protein cross-linking, 802 
allowing the liver to function normally (213), and also stripped copper from metallothionein 803 
(222).  Insoluble forms of copper were not observed.  Lastly, and in contrast to other chelators 804 
used for the treatment of Wilson disease, mb-OB3b was shown to work in circumstances of 805 
advanced liver failure, further suggesting that mb may be a viable alternative in the treatment of 806 
Wilson’s disease in the future. It is also tempting to speculate that the use of mbs may be of 807 
interest in other copper-associated pathologies as well, including certain forms of cancer (223-808 
226). For example, it was recently reported that active oncogenesis of a wide variety of cancers 809 
is directly affected the presence of copper through the role of BRAF kinase (226), since 810 
disrupting kinase copper binding through site-directed mutagenesis or preventing copper uptake 811 
through the addition of tetrathiomolybdate inhibited tumorigenesis. In our view, these 812 
observations make it clear that mbs, first discovered as an elusive factor associated with the 813 
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exclusively bacterial process of methane utilization, may hold great promise as useful molecules 814 
to humankind as well. 815 
 816 
CONCLUSIONS 817 
 The combination of heterocyclic ring and an associated thioamide is a unique structural 818 
feature of mbs among all natural products, and the primary cause of the capabilities observed for 819 
these molecules.  Although rare, oxazolone and imidazolone rings have been identified in several 820 
ribosomally synthesized and post-translationally modified natural products, and this feature 821 
appears to be responsible for the observed antimicrobial and metal binding properties of such 822 
molecules.  Pyrazinediones, in contrast, have so far only been observed in two non-ribosomally 823 
synthesized natural products, selerominol and flutimide, which show activity against several 824 
cancer cell lines and antiviral activity, respectively. As for thioamide groups, they also confer 825 
antimicrobial and metal binding properties in the two natural products identified so far that 826 
contain this functional group.  Crucially, combining both these structural features in small 827 
peptide derivatives such as mbs appears to enhance properties including copper acquisition, 828 
metal detoxification, detoxification of reactive oxygen species, electron transfer, nanoparticle 829 
formation, and gene regulation.  Production of high concentrations of mbs by a ubiquitous 830 
microbial group also raises a number of ecological questions such as of its effects on metal 831 
bioavailability and mobilization, as well as on the structure and functioning of microbial 832 
communities in the environment.  From an application viewpoint, mbs now have demonstrated 833 
potential for the production of nanoparticles as well as in the treatment of copper-related 834 
diseases, and we predict a variety of other commercial and medical applications have yet to be 835 
identified. 836 
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Figure Legends 841 
Fig. 1. Chemical structures of full-length mbs from M. trichosporium OB3b (A) (141, 151), 842 
Methylocystis strain sp.M (B)(133), M. hirsuta CSC1 (C)(133), M. rosea (D)(133) and 843 
Methylocystis strain sp. SB2 (E)(132). Stared amino acids are observed in some but not 844 
all samples. 845 
Fig. 2. Core features of mbs.  Abbreviations; AA, amino acid(s); AA – amine, amino acid minus 846 
amine group. R-groups can be Arg, Ile, Met, or Pro. 847 
Fig. 3. Structures of Cu1+-mb-OB3b (A), and the Cu1+-mbs from Methylocystis strain sp. M (B) 848 
and M. hirsuta CSC1 (C), both with a Thr residue missing at the C-terminus compared to 849 
the largest form isolated. The copper ions are represented as gray spheres, the oxazolone 850 
(oxa) and pyrazinedione (pyra) rings are labeled as are the coordinating atoms. 851 
Hydrogen-bonding interactions are shown in (B) and (C) as dashed orange lines. 852 
Fig. 4. Mb precursor peptides. Sequences were detected in bacteria of known genome sequence, 853 
from methanotrophs with structurally characterized mbs as well as from other 854 
methanotrophs; and from selected non-methanotrophs, directly from the DNA sequence 855 
using Fuzztran in Mobyle (http://mobyle.pasteur.fr), with the optimized mb sequence 856 
motif (Prosite format) [ILMV]-[AIKST](1,3)-[IV]-[KNRT]-[IV]-X-[AKQ]-[KRT]-X-857 
[ILM]-X-[IV]-X-[GV]-R-X(2)-[AL]-X-C(1,2)-[GA](0,1)-[ST](0,2)-X(0,2)-C(1,2) as a 858 
query. Only sequences also featuring downstream mb biosynthesis cassette genes mbnB 859 
and mbnC (see text, and Table 2) are shown.  Known and predicted leader sequences and 860 
sequences not observed in the final product are shown in black, sequences detected in 861 
bacteria of known genome sequence from methanotrophs with mbs whose primary 862 
structures have been determined are shown in red, sequences detected in bacteria of 863 
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known genome sequence from methanotrophs are shown in blue, and sequences detected 864 
in bacteria of known genome sequence from non-methanotrophs are shown in green.  865 
Amino acids observed in some but not all samples are shown in tan.  Grey background 866 
amino acids represent the amino acid pair shown or predicted to be post-translationally 867 
modified into an oxazolone, imidazolone or pyrazinedione group in structurally 868 
characterized mbs; underlined C represent Cys residues known or predicted to be present 869 
in the mature peptide. Abbreviations: mb from M. trichosporium OB3b (mb-OB3b), 870 
Methylosinus sp. strains LW3 (mb-LW3), LW4 (mb-LW4), PW1 (mb-PW1), M. parvus 871 
OBBP (mb-OBBP), M. rosea (mb-rosea), Methylocystis strains SB2 (mb-SB2), SC2 (mb-872 
SC2), and LW5 (mb-LW5), Cupriavidus basiliensis B-8 (mb-B-8), Pseudomonas 873 
extremaustralis 14-3 (mb-14-3), Azospirillum sp. strain B510 (mb-B510), Tistrella 874 
mobilis KA081020-065 (mb-mobilis), Comamonas composti DSM 21721 (mb-21721) 875 
and Gluconoacetobacter sp. strain SXCC. Numbers in brackets after strain are used in 876 
species with more than one mb gene cluster. Stop codons are indicated by a star, and gaps 877 
in the sequence alignment by a hyphen. 878 
 879 
Fig. 5. Mb gene clusters. Gene clusters of complete genomes of methanotrophs M. trichosporium 880 
OB3b (OB3b), Methylocystis sp. SB2 and M. rosea SV97 (SB2/SV97) that produce mb 881 
whose primary structure are  known (Fig. 1). Shown are the gene for the mb peptide 882 
precursor mbnA (black) and associated genes for the mb biosynthesis cassette protein 883 
MbnB (red), mb biosynthesis cassette protein MbnC (orange), MATE efflux pump MbnM 884 
(dark brown), aminotransferase MbnN (yellow), di-heme cytochrome c peroxidase MbnH 885 
(dark green) and associated MbnP of unknown function (light green), FAD-dependent 886 
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oxidoreductase MbnF (violet), sulfotransferase MbnS (dark blue), TonB-dependent 887 
receptor domain MbnT (light brown), FecI-like RNA polymerase sigma-70 domain MbnI 888 
(light blue), and FecR-like membrane sensor MbnR (light purple). Other genes of unknown 889 
function are shown in white, and genes flanking the clusters with predicted functions not 890 
thought to be associated with mb maturation or transport are shown in grey. 891 
Fig. 6. Proposed reaction schemes for biosynthesis of the oxazoline rings with associated 892 
thioamide groups via a tandem two-step sequence of peroxidation and dehydration 893 
reactions.  Cysteine thiols are likely protected against oxidation, possibly as disulfides 894 
involving one of the proteins of the mb gene cluster (blue circles).  For imidazolone and 895 
pyrazinedione ring formation, oxazolone rings are modified via a 896 
transamination/deamination step followed by an aminolysis step to open the oxazolone 897 
ring followed by ring formation and dehydration. 898 
Fig. 7.  Model for the regulation of gene expression in mmo, pmo and mbn gene clusters by 899 
copper, mb and MmoD.  (A) low copper : biomass ratio; (B) high copper : biomass ratio. 900 
From Semrau et al. (187). 901 
Fig. 8.  Revised regulatory scheme for expression of mmo, pmo and mbn gene clusters as a 902 
function of copper, mb and MbnI.  (A) low copper : biomass ratio; (B) high copper : 903 
biomass ratio. 904 
Fig. 9. Transmission electron micrographs of wild type M. trichosporium OB3b (A and B), M. 905 
trichosporium OB3b sMMO deletion mutant (C and D) and M. trichosporium OB3b mb 906 
deletion mutant (E and F) cultured in nitrate mineral salts medium (A, C and D) and 907 
NMS medium amended with 5 µM CuSO4 (B, D, and F). 908 
 43
Cover Figure. Physiological functions and potential commercial and medical applications of 909 
methanobactin (center structure), a post translationally modified copper binding 910 
protein. 911 
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Table 1. Metal binding affinities, K, of mbs from M. trichosporium OB3b (mb-OB3b), Methylocystis strain M (mb-M), Methylocystis hirsuta CSC1 (mb-CSC1), 
Methylocystis rosea (mb-rosea), and Methylocystis strain SB2 (mb-SB2).  Abbreviations, ITC, isothermal titration calorimetry; PT, potentiometric titration; DITC, 
displacement isothermal titration calorimetry; mb, methanobactin; mb2, mb dimer; mb4, mb tetramer; UTF, unable to fit; BCS, bathocuproine disulfonate; 
TRIEN, triethylenetetramine. 
 
       K (M-1)    
mb Method pH Reference Cu1+ Cu+2 Cu2+/Cu1+ a Au3+ Ag1+ Hg2+ Pb2+ 
mb4-OB3b ITC  6.8 140, 148 - - 3.2 x 1034 1.0 x 1040 - UTF - 
mb2-OB3b  6.8  - - 2.6 x 108 1.0 x 105 2.6 x 107 9.9 x 109 - 
mb-OB3b  6.8  - - 6.5 x 106 1.8 x 105 4.7 x 104 9.0 x 105 6.8 x 105 
mb4-OB3b PT 6.8 172 - - 1.0 x 1058 - - - - 
mb2-OB3b  6.8  - - 1.0 x 1052 - - - - 
mb-OB3b  6.8  - - 1.0 x 1025 - - - - 
mb-OB3b Competition titrations with BCS 7.5 141 ~7 × 1020  -     
mb-OB3b  7.5  - ~3 × 1012 b  - - - - 
mb-M Competition against mb-OB3b  7.5 133 ~1 × 1021   - - - - 
mb-M  7.5   ~2 × 1011 b - - - - - 
mb-CSC1 Competition titrations with BCS 7.5 133 ~7 × 1020   - - - - 
mb-CSC1  7.5   ~5 × 1014 b - - - - - 
mb-rosea c Competition against mb-OB3b 7.5 133 ~5 × 1020 -  - - - - 
mb-rosea  7.5   ~7 × 1011 b - - - - - 
mb4-SB2 DITC 6.9  154 - - 7.6 x 1026 - - - - 
mb2-SB2 DITC 6.6  - - 1.2 x 109 - - - - 
mb-SB2 DITC 6.9  - - 1.0 x 106 - - - - 
mb-SB2 Competition titrations with TRIEN 6.8  - - 1.9 x 1027     
mb-SB2 ITC 6.8  - - - - 1.2 x 108 - - 
       K (M-1)    
mb Method pH Reference  Cd2+ Co2+ Fe3+ Mn2+ Ni2+ Zn2+ 
mb4-OB3b ITC 6.8 148  1.3 x 106 - 9.7 x 105 - - 4.5 x 106 
mb2-OB3b  6.8   1.1 x 107 1.1 x 106 1.7 x 105 7.7 x 105 4.9 x 105 1.8 x 104 
a Copper added as Cu2+and therefore the  oxidation state of the copper bound by mb is in question due to its ability to reduce Cu2+ to Cu1+. 
b Calculated using the reduction potential of the Cu2+-mb/Cu1+-mb couple. 
c For the form of mb-rosea missing the C-terminal Asn and Thr residues. 
 
Table 2 Genes in methanobactin gene cluster. 
 
Gene Proposed Annotation Characteristics/Comments Interproscan ID 
mbnA Mb peptide precursor short ORF with N-terminal leader 
peptide 
N/A 
mbnB mb biosynthesis cassette 
protein MbnB 
TIM barrel enzyme (aldolase/isomerase 
type) 
IPR026432, 
IPR0078801 
mbnC mb biosynthesis cassette 
protein MbnC 
Less well defined than MbnB IPR023973 
mbnE FAD-dependent 
oxidoreductase 
often also found when mbnH and mbnP 
are missing 
IPR003042 
mbnH di-heme cytochrome c 
peroxidase 
 IPR023929, 
IPR004852 
mbnI RNA polymerase siga-
70 domain 
Putative σ70 factor. In some cases (e.g. 
strains SB2, SC2, SV97), 
methanobactin precursor peptide is the 
C-terminal peptide of MbnI 
 
mbnM MATE efflux pump multi antimicrobial extrusion protein  IPR004839, 
IPR005814 
mbnN aminotransferase rarely found (e.g. strain OB3b, LW4), 
pyridoxal-phosphate dependent 
IPR023977 
mbnP partner of mbnH conserved protein of unknown function  
mbnR  FecR-like, putative sigma factor 
activator 
IPR000863 
mbnS sulfotransferase rarely found (e. g. strain SB2, SC2, 
SV97); sulfonation of Thr? 
IPR012373 
mbmT TonB-dependent 
receptor 
plug domain, large membrane protein 
family 
IPR000531 
 

